Deal-making continued at a blistering pace in the first half of 2007, as drug giants snapped up promising therapies from smaller developers in order to beef up their pipelines. See the companies below for a look at the biggest deals so far this year.
1. AstraZeneca and Bristol-Myers Squibb [1]
2. Novartis and Antisoma [2]
3. Shire and Renovo [3]
4. Sanofi-Aventis and Oxford BioMedica [4]
5. Amgen and Cytokinetics [5]
Links:
[1] http://www.fiercebiotech.com/special-reports/astrazeneca-and-bristol-myers-squibb
[2] http://www.fiercebiotech.com/special-reports/novartis-and-antisoma
[3] http://www.fiercebiotech.com/special-reports/shire-and-renovo
[4] http://www.fiercebiotech.com/special-reports/sanofi-aventis-and-oxford-biomedica
[5] http://www.fiercebiotech.com/special-reports/amgen-and-cytokinetics